Journal of International Oncology ›› 2025, Vol. 52 ›› Issue (3): 158-162.doi: 10.3760/cma.j.cn371439-20240830-00024
• Original Article • Previous Articles Next Articles
Han Tao, Jia Peipei, Lu Jing()
Received:
2024-08-30
Revised:
2024-11-19
Online:
2025-03-08
Published:
2025-04-02
Contact:
Lu Jing,Email:Han Tao, Jia Peipei, Lu Jing. Predictive value of iRhom1,iRhom2 and TNF-α levels for the prognosis of patients with cervical cancer[J]. Journal of International Oncology, 2025, 52(3): 158-162.
"
一般临床资料 | 预后不良组 (n=21) | 预后良好组 (n=69) | t/χ2值 | P值 |
---|---|---|---|---|
年龄(岁) | 46.81±5.07 | 45.58±4.65 | 1.04 | 0.302 |
生育史 | ||||
有 | 18 | 62 | 0.02 | 0.895 |
无 | 3 | 7 | ||
FIGO 2018分期 | ||||
Ⅰ期 | 3 | 20 | ||
ⅡA1 | 10 | 38 | 5.27 | 0.072 |
ⅢC1r | 8 | 11 | ||
病理类型 | ||||
腺癌 | 5 | 13 | ||
鳞状细胞癌 | 14 | 51 | 0.74 | 0.701 |
腺鳞癌 | 2 | 5 | ||
切缘阳性 | ||||
是 | 12 | 28 | 1.79 | 0.181 |
否 | 9 | 41 | ||
淋巴结转移 | ||||
是 | 3 | 6 | 0.11 | 0.740 |
否 | 18 | 63 | ||
宫旁浸润 | ||||
是 | 8 | 11 | 3.51 | 0.061 |
否 | 13 | 58 | ||
浸润程度 | ||||
<1/2 | 10 | 48 | 3.38 | 0.066 |
≥1/2 | 11 | 21 | ||
肿瘤最大径(cm) | 3.84±0.24 | 3.77±0.21 | 1.27 | 0.206 |
[1] | 高福锋, 张师前. 子宫颈癌的预防与规范化诊疗[J]. 中国临床医生杂志, 2023, 51(3): 258-263. DOI: 10.3969/j.issn.2095-8552.2023.03.002. |
[2] | 赵新月, 胡莉钧. 局部晚期宫颈癌预后影响因素的研究进展[J]. 癌症进展, 2023, 21(15): 1635-1638. DOI: 10.11877/j.issn.1672-1535.2023.21.15.04. |
[3] | 汤怀鹏, 冉启玉, 周佳玲, 等. 根治性子宫切除术前宫颈锥切对早期宫颈癌患者预后影响研究进展[J]. 现代妇产科进展, 2022, 31(12): 956-958. DOI: 10.13283/j.cnki.xdfckjz.2022.12.013. |
[4] | 于婷, 李芝伟, 刘莎, 等. 早期宫颈癌锥切标本病理因素预测淋巴结转移风险的研究进展[J]. 现代肿瘤医学, 2023, 31(11): 2161-2163. DOI: 10.3969/j.issn.1672-4992.2023.11.034. |
[5] | Geesala R, Issuree PD, Maretzky T. Novel functions of inactive rhomboid proteins in immunity and disease[J]. J Leukoc Biol, 2019, 106(4): 823-835. DOI: 10.1002/JLB.3VMR0219-069R. |
[6] | Lee MY, Nam KH, Choi KC. iRhoms; its functions and essential roles[J]. Biomol Ther (Seoul), 2016, 24(2): 109-114. DOI: 10.4062/biomolther.2015.149. |
[7] | Sieber B, Lu F, Stribbling SM, et al. iRhom2 regulates ERBB signalling to promote KRAS-driven tumour growth of lung cancer cells[J]. J Cell Sci, 2022, 135(17): jcs259949. DOI: 10.1242/jcs.259949. |
[8] | Oikonomidi I, Burbridge E, Cavadas M, et al. iTAP, a novel iRhom interactor, controls TNF secretion by policing the stability of iRhom/TACE[J]. Elife, 2018, 7: e35032. DOI: 10.7554/eLife.35032. |
[9] | 中国抗癌协会妇科肿瘤专业委员会. 子宫颈癌诊断与治疗指南(2021年版)[J]. 中国癌症杂志, 2021, 31(6): 474-489. DOI: 10.19401/j.cnki.1007-3639.2021.06.06. |
[10] | 中国医师协会微无创医学专业委员会妇科肿瘤学组专业委员会, 中国妇幼保健协会生育力保存专业委员会. 早期子宫颈癌保留生育功能手术的中国专家共识[J]. 中国微创外科杂志, 2021, 21(8): 673-679. DOI: 10.3969/j.issn.1009-6604.2021.08.001. |
[11] | 李静, 索红燕, 孔为民. 《国际妇产科联盟(FIGO)2018癌症报告: 宫颈癌新分期及诊治指南》解读[J]. 中国临床医生杂志, 2019, 47(6): 646-649. DOI: 10.3969/j.issn.2095-8552.2019.06.008. |
[12] | Zhao X, Wang B, Zhuang Y, et al. Single high-dose irradiation-induced iRhom2 upregulation promotes macrophage antitumor activity through cGAS/STING signaling[J]. Int J Radiat Oncol Biol Phys, 2023, 116(5): 1150-1162. DOI: 10.1016/j.ijrobp.2023.02.013. |
[13] |
Blaydon DC, Etheridge SL, Risk JM, et al. RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome[J]. Am J Hum Genet, 2012, 90(2): 340-346. DOI: 10.1016/j.ajhg.2011.12.008.
pmid: 22265016 |
[14] |
Agwae ME, Shaw RJ, Triantafyllou A, et al. iRhom2 in the pathogenesis of oral squamous cell carcinoma[J]. Mol Biol Rep, 2020, 47(5): 3987-3992. DOI: 10.1007/s11033-020-05381-y.
pmid: 32236893 |
[15] |
Adrain C, Zettl M, Christova Y, et al. Tumor necrosis factor signa-ling requires iRhom2 to promote trafficking and activation of TACE[J]. Science, 2012, 335(6065): 225-228. DOI: 10.1126/science.1214400.
pmid: 22246777 |
[16] |
Luo Z, Huang Y, Batra N, et al. Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy[J]. Nat Commun, 2024, 15(1): 255. DOI: 10.1038/s41467-023-44572-6.
pmid: 38177179 |
[17] | Al-Salihi MA, Lang PA. iRhom2: an emerging adaptor regulating immunity and disease[J]. Int J Mol Sci, 2020, 21(18): 6570. DOI: 10.3390/ijms21186570. |
[18] | Badenes M, Adrain C. iRhom2 and TNF: partners or enemies?[J]. Sci Signal, 2019, 12(605): eaaz0444. DOI: 10.1126/scisignal.aaz0444. |
[19] |
Giese AA, Babendreyer A, Krappen P, et al. Inflammatory activation of surface molecule shedding by upregulation of the pseudoprotease iRhom2 in colon epithelial cells[J]. Sci Rep, 2021, 11(1): 24230. DOI: 10.1038/s41598-021-03522-2.
pmid: 34930929 |
[20] |
Zhao Z, Kesti T, Uğurlu H, et al. Tyrosine phosphorylation directs TACE into extracellular vesicles via unconventional secretion[J]. Traffic, 2019, 20(3): 202-212. DOI: 10.1111/tra.12630.
pmid: 30569492 |
[21] |
Xu Q, Chen C, Liu B, et al. Association of iRhom1 and iRhom2 expression with prognosis in patients with cervical cancer and possible signaling pathways[J]. Oncol Rep, 2020, 43(1): 41-54. DOI: 10.3892/or.2019.7389.
pmid: 31661139 |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||